Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-106547
Filing Date
2026-03-13
Accepted
2026-03-13 18:00:09
Documents
1
Period of Report
2026-03-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5163
  Complete submission text file 0001193125-26-106547.txt   6614
Mailing Address C/O ATEA PHARMACEUTICALS, INC. 225 FRANKLIN STREET SUITE 2100 BOSTON MA
Business Address
Corcoran Andrea (Reporting) CIK: 0001296996 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39661 | Film No.: 26753752

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 (857) 284-8891
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)